首页   按字顺浏览 期刊浏览 卷期浏览 Evaluation of Plasminogen Activators and Plasminogen Activator Inhibitors in Plasma and...
Evaluation of Plasminogen Activators and Plasminogen Activator Inhibitors in Plasma and Amniotic Fluid in Pregnancies Complicated with Intrauterine Fetal Growth Retardation

 

作者: Juan Gilaberta,   Amparo Estellés,   M. José Ayuso,   Francisco España,   Melitina Chirivella,   Salvador Grancha,   José M. Micó,   Justo Aznar,  

 

期刊: Gynecologic and Obstetric Investigation  (Karger Available online 1994)
卷期: Volume 38, issue 3  

页码: 157-162

 

ISSN:0378-7346

 

年代: 1994

 

DOI:10.1159/000292470

 

出版商: S. Karger AG

 

关键词: Fetal growth retardation;Pregnancy;Fibrinolysis;Preeclampsia;Plasminogen activator inhibitors;Amniotic fluid

 

数据来源: Karger

 

摘要:

Several fibrinolytic parameters were determined in plasma and amniotic fluid from normotensive pregnancies complicated by intrauterine fetal growth retardation (IUGR) and severe preeclamptic (PE) patients with IUGR and compared with data from normal pregnancies. A significant decrease in plasminogen activator type 2 (PAI-2) and urokinase levels in plasma and amniotic fluid was observed in IUGR groups in comparison with normal pregnancy. No significant differences were observed between the control and IUGR groups in relation to the other fibrinolytic parameters, except for plasma PAI type 1 and tissue-type plasminogen activator levels, which were significantly increased in the PE group. A significant positive correlation was observed between birth weight and PAI-2 levels in both plasma and amniotic fluid, but the plasma PAI-2 levels showed a higher correlation. In conclusion, these results suggest that the PAI-2 level measured in plasma is a more adequate marker of placental function than the PAI-2 level measured in amniotic fluid.

 

点击下载:  PDF (2537KB)



返 回